Lung Cancer

2021 ◽  
pp. 162-168
Author(s):  
Marianne Davies

Lung cancer is the leading cause of cancer-related deaths worldwide. Most patients are diagnosed with late-stage disease. Ninety percent of lung cancer cases can be attributed to tobacco smoking. Smoking cessation efforts have led to reductions in cancer-related deaths. Early screening can help to diagnose patients at earlier stages with improved outcomes. Lung cancer patients suffer the highest symptom burden and psychological distress above other cancers. Symptom burden is due to late-stage disease and treatment side effects. Psychological distress, anxiety, and depression are influenced by internal and external stigma. These lead to the negative impact on quality of life for lung cancer patients as well as family caregivers. Lung cancer–specific tools have been developed to assist in the screening and identification of distress, stigma, and quality-of-life metrics for lung cancer patients. Several organizations have formed to support the educational and psychological needs of lung cancer patients. Early assessment of symptom and psychological distress and integration of palliative care services can improve the quality of life of patients with lung cancer.

2021 ◽  
Vol 12 (2-3) ◽  
pp. 61-66
Author(s):  
Paraskevi Prapa ◽  
Ioanna V. Papathanasiou ◽  
Vissarion Bakalis ◽  
Foteini Malli ◽  
Dimitrios Papagiannis ◽  
...  

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e23187-e23187
Author(s):  
Fan Zhang ◽  
Junyan Wang ◽  
Lei Hong ◽  
Yu Xu ◽  
Da Jiang ◽  
...  

e23187 Background: Most patients with lung cancer have psychological problems, which has a significant impact on patients' rehabilitation, treatment and quality of life. Through the distress and quality of life assessment, to understand the risk factors of distress, in order to improve the quality of life of lung cancer patients. Methods: The investigation was consisted of 209 lung cancer patients who were treated in Fourth Hospital of Hebei Medical University from February 2014 to December 2015.Patients were assessed through the use of distress thermometer, problem list, quality of life questionnaire. Lung cancer patients were divided into a significant distress group and a non-significant distress group. Chi-square test was used to analyze the relationship between demographic characteristics, disease information and significant distress. Logistic regression analysis was used to analyze risk factors for distress. The Spearman rank correlation was used to analyze the correlation between the significant distress group and each area of the quality of life questionnaire. The test level was significantly different at P< 0.05. Results: The distress of majority lung cancer patients was 0-4 points, 68 cases were significant distress, significant distress rate was 32.5%. Logistic regression showed PS scores, family residence, informed condition were risk factors of significant distress( P< 0.001 < P= 0.035, P= 0.031). Economic problems were the most common cause of psychological distress in lung cancer patients. Other risk factors included the lack of time and energy to take care for the elderly/children, fear, sadness, dizziness and pain. The significant distress of lung cancer patients was negatively correlated with health status, physical function, emotional function, cognitive function, social function, and was positively correlated with symptoms as fatigue, nausea and vomiting, pain, shortness of breath, insomnia, loss of appetite and constipation. Conclusions: The incidence of significant distress in patients with lung cancer is 32.5%. PS score, fully informed, and family residence are the risks of significant distress in patients. The distress of lung cancer patients is significantly related to the quality of life.


2014 ◽  
Vol 13 (3) ◽  
pp. 575-581 ◽  
Author(s):  
Mare Nishiura ◽  
Atsuhisa Tamura ◽  
Hideaki Nagai ◽  
Eisuke Matsushima

AbstractObjective:We investigated the prevalence of sleep disturbance and psychological distress in lung cancer patients. We also examined the association between sleep disturbance and psychological distress, pain, fatigue, and quality of life in the same population.Method:Fifty lung cancer patients were evaluated. Sleep disturbance was assessed using the Athens Sleep Insomnia Scale (AIS) and psychological distress using the Hospital Anxiety and Depression Scale (HADS). Quality of life (QOL), pain, and fatigue were assessed employing the European Organization of Research and Treatment Quality of Life Questionnaire–Cancer 30 (EORTC QLQ–C30).Results:We observed that 56% of lung cancer patients had sleep disturbance (AIS score ≥6) and 60% had psychological distress (total HADS score ≥11). Patients with sleep disturbance had a HADS score of 14.6 ± 5.8, a fatigue score of 45.3 ± 22.0, and a pain score of 27.2 ± 26.2. In contrast, patients without sleep disturbance had a lower HADS score of 9.9 ± 8.1 (p < 0.05) and a higher fatigue score of 28.5 ± 18.0 (p < 0.01) and a pain score of 8.7 ± 15.8 (p < 0.01). In addition, we found a lower QOL in patients with sleep disturbance (46.3 ± 20.2) than in those without (65.2 ± 20.7) (p < 0.05). We also observed a significant correlation between the AIS, HADS, fatigue, QOL, and pain scores.Significance of Results:Lung cancer patients suffered from combined symptoms related to sleep. Sleeping pills improved sleep induction but were not sufficient to provide sleep quality and prevent daytime dysfunction. Daytime dysfunction was specifically associated with psychological distress. Additionally, the type of sleep disturbance was related to other patient factors, including whether or not they received chemotherapy.


Cureus ◽  
2021 ◽  
Author(s):  
Evangelos C Fradelos ◽  
Eleni Albani ◽  
Ioanna V Papathanasiou ◽  
Paraskevi-Maria Prapa ◽  
Effrosyni Tsomaka ◽  
...  

Author(s):  
Lorenzo Anelli ◽  
Alessia Di Nardo ◽  
Massimo Bonucci

Abstract Introduction A retrospective clinical study was performed to identify the characteristics of patients with lung cancer treated with integrative cancer treatment in addition to conventional medicine. Materials and Methods We reviewed medical records for lung cancer patients who visited a single integrative setting in Rome, Italy. A total of 57 patients were included, and the majority had advanced-stage cancer. All of them underwent integrative therapy with nutrition and phytotherapy indications. The diet was designed to reduce most of possible factors promoting cancer proliferation, inflammation, and obesity. Foods with anti-inflammatory, prebiotic, antioxidant, and anticancer properties had been chosen. Herbal supplements with known effects on lung cancer were prescribed. In particular, astragal, apigenine, fucosterol, polydatin, epigallocatechin gallate, cannabis, curcumin, and inositol were used. Furthermore, medical mushrooms and other substances were used to improve the immune system and to reduce chemotherapy side effects. Five key parameters have been evaluated for 2 years starting at the first surgery: nutritional status, immune status, discontinuation of therapy, quality of life, and prognosis of the disease. Results A relevant improvement in parameters relative to nutritional status, immune status, and quality of life has been observed after integrative therapy compared with the same parameters at the first medical visit before starting such approach. Conclusion The results suggest that integrative therapy may have benefits in patients with lung cancer. Even though there are limitations, the study suggests that integrative therapy could improve nutritional status and quality of life, with possible positive effect on overall survival.


Sign in / Sign up

Export Citation Format

Share Document